GlassScriptPhysician profile
Les M Alloju
NPI 1407273659
$1,356.75
in general payments reported to CMS, 2019-2025
18 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $231 · 2022: $138 · 2023: $130 · 2024: $379 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Education: $56.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.41 |
| Education | $56.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $286.52 | 2022-2025 | Propel |
| Acclarent, INC | $205.12 | 2021-2024 | Acclarent Aera |
| Genzyme Corporation | $177.54 | 2023-2025 | |
| Inspire Medical Systems, INC. | $122.03 | 2024-2025 | Inspire |
| Stryker Corporation | $109.34 | 2021-2024 | Scopis Ent |
| Aerin Medical INC. | $83.69 | 2023-2024 | |
| Glaxosmithkline, LLC. | $57.11 | 2022-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $56.99 | 2025 | |
| Integra Lifesciences Corporation | $47.24 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $37.03 | 2022 | |
| Optinose US, INC. | $35.16 | 2023-2024 | |
| Baxter Healthcare | $29.65 | 2021 | |
| Phadia US INC. | $25.52 | 2024 | Immunocap |
| Kerecis Limited | $21.39 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $19.00 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $15.83 | 2024 | Karbinal |
| Hikma Pharmaceuticals USA | $14.61 | 2025 | Ryaltris |
| Galderma Laboratories, L.P. | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Les Alloju listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.